Case Report on the Use of Cyclosporine solution for the treatment of Oral Graft versus host disease (GVHD) after BMT

[1]  J. Epstein,et al.  Budesonide for local therapy of complex oral mucosal immune-mediated inflammatory diseases: case reports. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[2]  M. Schubert,et al.  Oral graft-versus-host disease. , 2008, Dental clinics of North America.

[3]  I. Kocyiğit,et al.  The effect of budesonide mouthwash on oral chronic graft versus host disease , 2007, American journal of hematology.

[4]  Steven Hirschfeld,et al.  Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report , 2006 .

[5]  T. Iwasaki.  Recent advances in the treatment of graft-versus-host disease. , 2004, Clinical medicine & research.

[6]  A. Eckardt,et al.  Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. , 2004, Oral oncology.

[7]  R. Rogers,et al.  Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. , 2004, Journal of periodontology.

[8]  S. Elad,et al.  Budesonide: a novel treatment for oral chronic graft versus host disease. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[9]  C. França,et al.  Severe oral manifestations of chronic graft-vs.-host disease. , 2001, The Journal of the American Dental Association (1939).

[10]  J. Epstein,et al.  Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[11]  N. Callander,et al.  Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[12]  S. Woo,et al.  Graft-vs.-host disease. , 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[13]  M. Harada,et al.  Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[14]  J. Epstein,et al.  Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. , 1996, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[15]  P. Ljungman,et al.  Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients. , 1994, Bone marrow transplantation.

[16]  Epstein Jb,et al.  Topical cyclosporin A for treatment of oral chronic graft-versus-host disease. , 1994 .

[17]  E. Shevach,et al.  Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway. , 1990, Journal of immunology.

[18]  D. Snover.  Acute and chronic graft versus host disease: histopathological evidence for two distinct pathogenetic mechanisms. , 1984, Human pathology.